source
- FDA’s radical transparency policy for rejections runs into legal uncertaintyHaving started to publish CRLs without consulting the public, the FDA is under pressure to change course amid concerns it failed to openly and fully evaluate a complex issue.BioSpace · 10d ago↗ source
- STAT+: A most-wanted fugitive appears to have been secretly working as a biotech executiveA former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech executive.STAT · 10d ago↗ source
- STAT+: Pharmalittle: We’re reading about a telehealth firm and patient safety, PBMs overcharging, and moreSome former employees say telehealth company LifeMD has sought to maximize the volume of GLP-1 prescriptions at the expense of patient safety